Huihuan Luo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Huihuan Luo has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Anni Li
School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and Key Lab of Health Technology Assessment of the Ministry of Health, Fudan University, Shanghai 200032, China
2 shared publications- Haidong Kan
Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, China; Children's Hospital of Fudan University, National Center for Children's Health, Shanghai, China
2 shared publications Kexin Yu
School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and Key Lab of Health Technology Assessment of the Ministry of Health, Fudan University, Shanghai 200032, China
2 shared publicationsLu Zhou
School of Public Health, Key Lab of Public Health Safety of the Ministry of Education and Key Lab of Health Technology Assessment of the Ministry of Health, Fudan University, Shanghai 200032, China
2 shared publications- Renjie Chen
Fudan University
2 shared publications - Xia Meng
School of Public Health, Key Laboratory of Public Health Safety of the Ministry of Education and Key Laboratory of Health Technology Assessment of the Ministry of Health, Fudan University, Shanghai 200032, China
2 shared publications
Latest Publications
- 14 May 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (4) , 108385
Air Pollution Elevates the Risks of Incident Hypertension, Subsequent Comorbidities Progression, and Prognosis: A Multistate Analysis
- 14 May 2026
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 71 (4) , 108385
Air Pollution Elevates the Risks of Incident Hypertension, Subsequent Comorbidities Progression, and Prognosis: A Multistate Analysis
- Open Access
- 5 September 2025
- Published by American Chemical Society (ACS) in Environment & Health
- Vol. 4 (1) , 65-73
Ambient Ultrafine Particulate Air Pollution and Incidence of Cardiovascular Diseases
Fine particulate matter (PM2.5) pollution is causally linked to cardiovascular diseases (CVDs), but the long-term effects of potentially more toxic ultrafine particles (UFP) are unclear. We evaluated the associations between long-term exposure to UFP concentrations and the incidence of overall and cause-specific CVDs in 453,692 middle-aged and older UK Biobank participants living >100 m from major roads, followed from 2006–2010 baseline to 2023. A Cox proportional hazard model was applied to estimate the hazard ratio (HR) and 95% confidence interval per interquartile range increment in UFP concentrations. Long-term exposure to ambient UFP was associated with a 3% higher incidence risk of overall CVD (95% CI: 1–4%). Significant positive associations were observed for several specific CVDs, including chronic rheumatic heart diseases, hypertension, ischemic heart diseases, conduction disorders, heart failure, and cerebrovascular diseases (HRs: 1.03–1.09), while others showed no association. These associations were generally robust to adjustment of other air pollutants including PM2.5. The exposure–response relationship curves were generally linear without thresholds. This large prospective study suggests that UFP is an independent, modifiable CVD risk factor, distinct from PM2.5, relevant even for populations distant from major emission sources. This highlights the need to consider UFP in air quality management and public health strategies.
- 5 September 2025
- Published by American Chemical Society (ACS) in Environment & Health
- Vol. 4 (1) , 65-73
Open AccessAmbient Ultrafine Particulate Air Pollution and Incidence of Cardiovascular Diseases
Fine particulate matter (PM2.5) pollution is causally linked to cardiovascular diseases (CVDs), but the long-term effects of potentially more toxic ultrafine particles (UFP) are unclear. We evaluated the associations between long-term exposure to UFP concentrations and the incidence of overall and cause-specific CVDs in 453,692 middle-aged and older UK Biobank participants living >100 m from major roads, followed from 2006–2010 baseline to 2023. A Cox proportional hazard model was applied to estimate the hazard ratio (HR) and 95% confidence interval per interquartile range increment in UFP concentrations. Long-term exposure to ambient UFP was associated with a 3% higher incidence risk of overall CVD (95% CI: 1–4%). Significant positive associations were observed for several specific CVDs, including chronic rheumatic heart diseases, hypertension, ischemic heart diseases, conduction disorders, heart failure, and cerebrovascular diseases (HRs: 1.03–1.09), while others showed no association. These associations were generally robust to adjustment of other air pollutants including PM2.5. The exposure–response relationship curves were generally linear without thresholds. This large prospective study suggests that UFP is an independent, modifiable CVD risk factor, distinct from PM2.5, relevant even for populations distant from major emission sources. This highlights the need to consider UFP in air quality management and public health strategies.
- Open Access
- 13 June 2024
- Published by Elsevier in Eco-Environment & Health
- Vol. 3 (4) , 445-451
Long-term exposure to air pollution and incidence risk of various arrhythmias: A prospective cohort study
- 13 June 2024
- Published by Elsevier in Eco-Environment & Health
- Vol. 3 (4) , 445-451
Open AccessLong-term exposure to air pollution and incidence risk of various arrhythmias: A prospective cohort study
- Open Access
- 7 April 2021
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (1) , E204-E212
Association between plasma free fatty acid levels and primary angle‐closure glaucoma based on a mass spectrometry metabolomics analysis
Purpose To determine the association between plasma free fatty acid (FFA) levels and primary angle‐closure glaucoma (PACG). Methods Free fatty acid (FFA) levels in patients with PACG (n = 181) and people without glaucoma (n = 340) were compared. Twenty‐two FFAs and six lipid classes were measured using metabolomics analysis. Odds ratio (OR) of these metabolites and their 95% confidence intervals (95%CI) for PACG were obtained by logistic regression. Stepwise forward selection was performed to identify FFAs that influenced PACG risk. Areas under the curve (AUC) were applied to assess the predictive performance. Spearman’s rank correlation was used to assess the relationship between ocular parameters and FFAs. Results Most FFAs in the PACG group were lower than those in the non‐glaucoma group. Docosahexaenoic acid (DHA; OR for fourth quartile (Q4) vs. first quartile (Q1): 0.32 (0.16–0.66); per standard deviation (SD) increase: 0.64 (0.49–0.83); p for trend: 0.0007) and total saturated fatty acids (SFAs; OR for Q4 versus Q1: 0.27 (0.13–0.56); per SD increase: 0.65 (0.50–0.87); p for trend: 0.0004) were associated with decreased PACG risk. The AUC of the model that included DHA, total SFAs, demographic and ophthalmic factors increased from 0.8230 (0.7811–0.8649) to 0.8512 (0.8133–0.8891) (increased AUC: 0.0282 (0.0112–0.0453); p for increased AUC: 0.0012). Additionally, the cup‐disc ratio had a weak negative correlation with DHA and total SFAs (DHA: r = −0.12085, p = 0.0065; total SFAs: r = −0.13318, p = 0.0024). Conclusions Decrease in FFA levels may be related to lipid peroxidation. Docosahexaenoic acid (DHA) and total SFAs may be screening indices for PACG patients.
- 7 April 2021
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (1) , E204-E212
Open AccessAssociation between plasma free fatty acid levels and primary angle‐closure glaucoma based on a mass spectrometry metabolomics analysis
Purpose To determine the association between plasma free fatty acid (FFA) levels and primary angle‐closure glaucoma (PACG). Methods Free fatty acid (FFA) levels in patients with PACG (n = 181) and people without glaucoma (n = 340) were compared. Twenty‐two FFAs and six lipid classes were measured using metabolomics analysis. Odds ratio (OR) of these metabolites and their 95% confidence intervals (95%CI) for PACG were obtained by logistic regression. Stepwise forward selection was performed to identify FFAs that influenced PACG risk. Areas under the curve (AUC) were applied to assess the predictive performance. Spearman’s rank correlation was used to assess the relationship between ocular parameters and FFAs. Results Most FFAs in the PACG group were lower than those in the non‐glaucoma group. Docosahexaenoic acid (DHA; OR for fourth quartile (Q4) vs. first quartile (Q1): 0.32 (0.16–0.66); per standard deviation (SD) increase: 0.64 (0.49–0.83); p for trend: 0.0007) and total saturated fatty acids (SFAs; OR for Q4 versus Q1: 0.27 (0.13–0.56); per SD increase: 0.65 (0.50–0.87); p for trend: 0.0004) were associated with decreased PACG risk. The AUC of the model that included DHA, total SFAs, demographic and ophthalmic factors increased from 0.8230 (0.7811–0.8649) to 0.8512 (0.8133–0.8891) (increased AUC: 0.0282 (0.0112–0.0453); p for increased AUC: 0.0012). Additionally, the cup‐disc ratio had a weak negative correlation with DHA and total SFAs (DHA: r = −0.12085, p = 0.0065; total SFAs: r = −0.13318, p = 0.0024). Conclusions Decrease in FFA levels may be related to lipid peroxidation. Docosahexaenoic acid (DHA) and total SFAs may be screening indices for PACG patients.